As inhibition of ribosome biogenesis is an emerging strategy for cancer therapy (Drygin et al., 2010; Hein et al., 2013), the role of PWP1 in the joint control of Pol I and Pol III makes PWP1 an appealing target. Here, PWP1 is linked to cancer.